Novartis's (NVS) Swiss stock has an average rating of hold and mean price target of CHF125.60, according to analysts polled by FactSet.
What else is happening in Research?
Research
UBS Downgrades Revvity to Neutral From Buy, Adjusts Price Target to $140 From $120
Revvity (RVTY) has an average rating of overweight and mean price target of $127.29, according to analysts polled by FactSet.
$RVTY
Research
UBS Downgrades Mettler-Toledo International to Neutral From Buy, Adjusts Price Target to $1,460 From $1,650
Mettler-Toledo International (MTD) has an average rating of hold and mean price target of $1,472.92, according to analysts polled by FactSet.
$MTD
Research
UBS Downgrades Agilent Technologies to Neutral From Buy, $165 Price Target
Agilent Technologies (A) has an average rating of overweight and mean price target of $175.58, according to analysts polled by FactSet.
$A